Concord Wealth Partners Penumbra Inc Transaction History

Concord Wealth Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$116.09 - $227.33 $2,205 - $4,319	-19 Reduced 73.08%	7 $1,000
Q1 2022 Apr 20, 2022	SELL	$187.51 - $283.98 $937 - $1,419	-5 Reduced 16.13%	26 $6,000
Q4 2021 Jan 21, 2022	BUY	$238.08 - $288.0 $3,333 - $4,032	14 Added 82.35%	31 $9,000
Q3 2021 Nov 09, 2021	BUY	$250.72 - $291.24 $3,510 - $4,077	14 Added 466.67%	17 $5,000
Q1 2021 May 13, 2021	BUY	$175.6 - $291.43 $526 - $874	3 New	3 $1,000

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.